Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty:A case report  

作　　者：Fang-Fang Lv Mei-Ye Li Wei Qu Zhao-Shun Jiang 

机构地区：[1]Department of Endocrinology,960th Hospital of PLA,Jinan 250014,Shandong Province,China

出　　处：《World Journal of Clinical Cases》2023年第26期6147-6153,共7页世界临床病例杂志

摘　　要：BACKGROUND Anticoagulation treatment after lower limb surgery is one of the key methods to avoid thrombosis,and low-molecular-weight heparin is the treatment that is most frequently used in clinical practice.But one uncommon side effect of lowmolecular-weight heparin is heparin-induced thrombocytopenia(HIT),which can develop into thrombosis if not caught early or managed incorrectly.CASE SUMMARY We present a case of a patient who underwent hip arthroplasty and experienced thrombocytopenia due to HIT on the 9th d following the application of lowmolecular-weight heparin anticoagulation.We did not diagnose HIT in time and applied 1 unit of platelets to the patient,which led to thrombosis.Luckily,the patient recovered following effective and timely surgery and treatment with rivaroxaban.CONCLUSION Patients using low-molecular-weight heparin after lower limb surgery need to have their platelet counts regularly checked.If HIT develops,platelet treatment should be given with caution.

关 键 词：Low-molecular-weight heparin Heparin-induced thrombocytopenia with thrombosis PLATELET Case report 

分 类 号：R973.2[医药卫生—药品]